Depressive symptoms are an important part of
bipolar disorder types I/II and contribute to significant morbidity and mortality. Establishing treatments for
bipolar disorder has been difficult; in fact, no existing treatments approved by the
FDA have been developed using an a priori disease model, and multiple failed clinical trials have suggested multiple biotypes within the […]